CIK 0001099800 · Large accelerated filer
Edwards Lifesciences Corp
Sign in to watch- Ticker
- EW
- Exchange
- NYSE
- Industry
- Orthopedic, Prosthetic & Surgical Appliances & Supplies
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 364316614
- Phone
- 9492502500
- Business address
- ONE EDWARDS WAY, IRVINE, CA, 92614
- Former names
- CVG CONTROLLED INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $10,886,105
- in 9 filings, $7.6M under 10b5-1 plans
Net −$10,886,105. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-01 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −19 | $83.99 | $2K | 34,933.91 |
| 2026-05-01 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −1,000 | $82.99 | $83K | 33,933.91 |
| 2026-05-01 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −1,019 | 1,019 | ||
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +13,000 | $59.26 | $770K | 52,699 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −4,676 | $80.50 | $376K | 48,023 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −8,324 | $79.79 | $664K | 39,699 |
| 2026-04-09 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −13,000 | 13,000 | ||
| 2026-04-06 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +1,019 | $59.26 | $60K | 34,952.91 |
| 2026-04-06 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −1,019 | $80.98 | $83K | 33,933.91 |
| 2026-04-06 | Lippis Daniel J. CVP, TAVR | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −1,019 | 2,038 | ||
| 2026-04-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise 10b5-1 | +22,680 | $59.26 | $1.3M | 43,946.25 |
| 2026-04-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −4,676 | $80.59 | $377K | 39,270.25 |
| 2026-04-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Sale 10b5-1 | −18,004 | $80.05 | $1.4M | 21,266.25 |
| 2026-04-02 | BOBO DONALD E JR CVP,Strategy/Corp Development | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −22,680 | 0 | ||
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise 10b5-1 | +13,000 | $59.26 | $770K | 52,699 |
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −5,099 | $84.46 | $431K | 47,600 |
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Sale 10b5-1 | −7,901 | $85.21 | $673K | 39,699 |
| 2026-03-11 | Ullem Scott B. CVP, Chief Financial Officer | Option exercise · Employee Stock Option (Right to Acquire) 10b5-1 | −13,000 | 26,000 | ||
| 2026-03-11 | Lippis Daniel J. CVP, TAVR | Option exercise 10b5-1 | +1,019 | $59.26 | $60K | 34,952.91 |
| 2026-03-11 | Lippis Daniel J. CVP, TAVR | Sale 10b5-1 | −1,019 | $85.38 | $87K | 33,933.91 |
Page 8 of 13 · 249 trades